DC-derived MHC class II molecules and tumor-derived antigenic peptides travel by separate routes and converge to form MHC class II-peptide complexes in DC-tumor FCs, where MHC class II-antigenic peptide complexes are expressed on the DC-tumor FC surface and presented to CD4+ T cells. Here, CD4 is linked to neoplasm.